Author Correction: Isogambogenic acid induces apoptosis-independent autophagic cell death in human non-small-cell lung carcinoma cells (Scientific Reports, (2015), 5, 1, (7697), 10.1038/srep07697);Isogambogenic acid induces apoptosis-independent autophagic cell death in human non-small-cell lung carcinoma cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yang, Jianhong ^a   Zhou, Yongzhao ^b   Cheng, Xia ^a   Fan, Yi ^a   He, Shichao ^a   Li, Shucai ^a   Ye, Haoyu ^a   Xie, Caifeng ^a   Wu, Wenshuang ^a   Li, Chunyan ^a   Pei, Heying ^a   Li, Luyuan ^c   Wei, Zhe ^a   Peng, Aihua ^a   Wei, Yuquan ^a   Li, Weimin ^b   Chen, Lijuan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; ATG7 PROTEIN, HUMAN; AUTOPHAGY RELATED PROTEIN 7; BECLIN 1; BECN1 PROTEIN, HUMAN; ISOGAMBOGENIC ACID; LIGHT CHAIN 3, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN KINASE B; RAPAMYCIN; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE; UBIQUITIN PROTEIN LIGASE; XANTHONE DERIVATIVE;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; AUTOPHAGY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; G1 PHASE CELL CYCLE CHECKPOINT; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 7; BECLIN-1; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SURVIVAL; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES; UBIQUITIN-ACTIVATING ENZYMES; XANTHONES;

EID: 84930527964     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-020-62992-y     Document Type: Erratum

References (51)

1. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int. J. Cancer 127, 2893-2917 (2010).
2. Ferreira, C. G., Tolis, C., Giaccone, G. p53 and chemosensitivity [J]. Ann. Oncol. 10, 1011-1021 (1999).
3. El-Deiry, W. S. The role of p53 in chemosensitivity and radiosensitivity [J]. Oncogene 22, 7486-7495 (2003).
4. White, E. Autophagic cell death unraveled: Pharmacological inhibition of apoptosis and autophagy enables necrosis. Autophagy 4, 399-401 (2008).
5. Shen, H. M., Codogno, P. Autophagic cell death: Loch Ness monster or endangered species Autophagy 7, 457-465 (2011).
6. Kondo, Y., Kondo, S. Autophagy and cancer therapy. Autophagy 2, 85-90 (2006).
7. Levy, J. M.&Thorburn, A. Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol. Ther. 131, 130-141 (2011).
8. Guo, W. J. et al. Novel monofunctional platinum (II) complex induces apoptosisindependent autophagic cell death in human ovarian carcinoma cells, distinct from cisplatin [J]. Autophagy 9, 996-1008 (2013).
9. O'Donovan, T. R., O'Sullivan, G. C.,McKenna, S. L. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7, 509-524 (2011).
10. Li, J., Hou, N., Faried, A., Tsutsumi, S., Kuwano, H. Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur. J. Cancer 46, 1900-1909 (2010).
11. Zhu, K., Dunner, K. J., McConkey, D. J. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 29, 451-462 (2010).
12. Vazquez-Martin, A., Oliveras-Ferraros, C., Menendez, J. A. Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. PLoS One 4, e6251 (2009).
13. Wu, Z. et al. Autophagy blockade sensitizes prostate cancer cells towards Src family kinase inhibitors. Genes Cancer 1, 40-49 (2010).
14. Mujumdar, N., Saluja, A. K. Autophagy in pancreatic cancer: an emerging mechanism of cell death. Autophagy 6, 997-998 (2010).
15. Yu, L. et al. Regulation of an Atg7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500-1502 (2004).
16. Amaravadi, R. K. et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 17, 654-656 (2011).
17. Liu, E. Y., Ryan, K. M. Autophagy and cancer-issues we need to digest. J. Cell Sci. 125, 2349-2358 (2012).
18. Xie, Z., Klionsky, D. J. Autophagosome formation: core machinery and adaptations. Nat. Cell Biol. 9, 1102-1109 (2007).
19. Geng, J., Klionsky, D. J. The Atg8 and Atg12 ubiquitinlike conjugation systems in macroautophagy. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep. 9, 859-864 (2008).
20. Kroemer, G., Marinõ, G., Levine, B. Autophagy and the integrated stress response. Mol. Cell 40, 280-293 (2010).
21. Yang, Z., Klionsky, D. J. Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 22, 124-131 (2010).
22. Pandey, M. K. et al. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kB signaling pathway [J]. Blood 110, 3517-3525 (2007).
23. Fan, Y. et al. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway. J. Chemother. 25, 298-308 (2013).
24. Klionsky, D. J., Cuervo, A. M., Seglen, P. O.Methods for monitoring autophagy from yeast to human. Autophagy 3, 181-206 (2007).
25. Moscat, J., Diaz-Meco, M. T. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137, 1001-1004 (2009).
26. Kroemer, G. et al. Nomenclature Committee on Cell Death 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16, 3-11 (2009).
27. Yang, Z., Klionsky, D. J. An overview of themolecular mechanism of autophagy. Curr. Top Microbiol. Immunol. 335, 1-32 (2009).
28. Luo, S., Rubinsztein, D. C. Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ. 14, 1247-1250 (2007).
29. Hanahan, D.&Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
30. Pouysségur, J., Dayan, F., Mazure, N. M. Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 441, 437-443 (2006).
31. Brown, E. J. et al. A mammalian protein targeted by G1-arresting rapamycinreceptor complex. Nature 369, 756-758 (1994).
32. Kunz, J. et al. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73, 585-596 (1993).
33. Jefferies, H. B. et al. Rapamycin suppresses 59 TOP mRNA translation through inhibition of p70s6k. EMBO J. 16, 3693-3704 (1997).
34. Beretta, L. et al. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15, 658-664 (1996).
35. Takeuchi, H. et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 65, 3336-3346 (2005).
36. Shi, Y., Yan, H., Frost, P., Gera, J., Lichtenstein, A. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by upregulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade. Mol. Cancer Ther. 4, 1533-1540 (2005).
37. O'Reilly, K. E. et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 66, 1500-1508 (2006).
38. Wan, X. et al. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26, 1932-1940 (2007).
39. Cirstea, D. et al. Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-boundrapamycin and perifosine induces antitumor activity in multiple myeloma. Mol. Cancer Ther. 9, 963-975 (2010).
40. Saiki, S. et al. Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy 7, 176-187 (2011).
41. Meschini, S. et al. The plant alkaloid voacamine induces apoptosis-independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells. Autophagy 4, 1020-1033 (2008).
42. Lin, J. et al. A novel Bcl-XL inhibitor Z36 that induces autophagic cell death in Hela cells. Autophagy 5, 314-520 (2009).
43. Yuk, J. M. et al. Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy. Autophagy 6, 46-60 (2010).
44. Barbet, N. C. TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell 7, 25-42 (1996).
45. Matsui, A., Kamada, Y., Matsuura, A. The Role of Autophagy in Genome Stability through Suppression of Abnormal Mitosis under Starvation [J]. PLoS genetics 9, e1003245 (2013).
46. Sun, S. Y., Hail, N. J., Lotan, R. Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer Inst. 96, 662-672 (2004).
47. 47.Vakifahmetoglu, H. et al.DNAdamage induces two distinct modes of cell death in ovarian carcinomas. Cell Death Differ. 15, 555-566 (2008).
48. Bröker, L. E., Kruyt, F., Giaccone, G. Cell death independent of caspases: a review. Clin. Cancer Res. 11, 3155-3162 (2005).
49. Chen, T. S. et al. Taxol induces caspase-independent cytoplasmic vacuolization and cell death through endoplasmic reticulum (ER) swelling in ASTC-a-1 cells. Cancer Lett. 270, 164-172 (2008).
50. Shimizu, S. et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 6, 1221-1228 (2004).
51. Wang, K. et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR-and hypoxia-induced factor 1a-mediated signaling. Autophagy, 7, 966-978 (2011).